2. What is NExA
• NEXA is a treatment clinic offering OMT (Opioid
Maintenance Treatment) since 2006.
• Our OMT is fully licensed by IDHS/DASA, certified by
CSAT, DEA (Drug Enforcement Agency), and CARF
International (Certification Accreditation for Rehabilitation
Facilities)
• OMT (Opioid Maintenance Treatment) is a program for
individuals with a history of chronic opiate dependence.
The treatment options H.A.S. offers for this type of
addiction include methadone maintenance treatment
(MMT) and suboxone treatment.
3. What We Do:
• The OMT program operates at a clinical setting, where
methadone serves as a replacement for heroin and other
opioids. This program is a long-term program that offers a
low cost alternative for treatment in which medical
supervision in conjunction with counseling and support has
proven effective.
• Suboxone Pilot Project: Suboxone is a medical alternative
for methadone treatment. As a medical alternative,
suboxone is available by prescription only for long-term
treatment for opioid dependence, it is used in conjunction
with a complete treatment plan that includes counseling and
support.
8. Employment
Challenges
• The majority of our participants have a low level of education and
in the employment market are considered un-skilled
• The average educational level among participants is up to 10th or
11th grade
• Most participants have a long history of refusing to follow
direction, which is an obstacle to finding stable employment
• A high number of participants have a criminal background
• Some participants have low self-esteem
• Criminal culture or Criminal Thinking (making quick bucks)
9. Streams Of revenue
• Client Fees (Cash Collections)
• Medicaid
• Chicago Department of Public Health (Ryan White)
• Aids Foundation of Chicago (Ryan White)
• Suboxone Project (Prescription Medication subsidized
by RICKET Pharmaceutical), Outpatient Treatment by
IDOC in conjunction with TASC case management.
10. Our Challenges
We currently have many participants with high balances, which
impacts our cash collections for the program
13. Our Challenges
• Sub-Culture:
a) Because of the long lasting length of the treatment
process, many participants have developed a
connection and know the “system”
b) Some participants manipulate the “system”, this is
challenging in our cash collection process
14. Our Challenges
• Stigma: Stigma refers to the negative attitudes (prejudice)
and negative behavior (discrimination) toward people with
substance use and mental health problems.
a) In order to address this stigma SAMHSA has adopted
new terminology for this type of treatment: MAT
(Medication-Assisted Treatment)
b) Add something about how stigma affects people attaining
a job,
c) MAT is the use of medications, in combination with
counseling and behavioral therapies, to provide a whole-
patient approach to treatment.
15. Opportunities
• Expand baseline of private participants and reach out to health
insurance networks (We have a contract with value options)
• Expand and enhance MAT (suboxone treatment) to other areas in
the city. (A better facility will facilitate this process)
• Market MAT as an option for pain management
• Continue Increasing Medicaid referrals by reaching out to
population in need for services
• Continue looking for public funding
• Expand Specialized MAT treatment for Criminal Justice
population
